newsfilter
← Latest News
GlobeNewswire·

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

CINCINATTI, Oh., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or "the Company") (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research,